How to evaluate healthcare RCM partners: a CFO’s guide

Most healthcare organizations evaluate RCM partners the wrong way. 

They issue an RFP, collect proposals with identical language about ‘AI-powered denial management’ and ‘technology-enabled revenue cycle,’ and score them on references and pricing. Then they pick the one with the best presentation. 

Six months later, they’re measuring outcomes against a baseline that nobody agreed on. 

This guide is for CFOs and VP Revenue Cycle leaders who want a sharper framework: what to measure, what to ask that RFPs rarely do, and which metrics distinguish capable partners from aspirational ones. 

The baseline problem 

The most common failure mode in RCM partner evaluation isn’t picking the wrong vendor. It’s starting without an agreed performance baseline. 

If you don’t know your current denial rate, overturn rate, time-to-appeal, claim abandonment rate, and cost-per-claim before signing a contract, you have no way to evaluate whether your new partner is improving anything. You’re measuring effort, not outcomes. 

Before issuing any RFP, pull these 6 figures from your current operation: 

BASELINE METRICS TO PULL BEFORE EVALUATING ANY RCM PARTNER 

1. Initial denial rate: What % of your claims are denied on first submission?
2. Overturn rate: What % of appealed denials are reversed?
3. Time-to-appeal: How many days from denial to submitted appeal? 
4. Claim abandonment rate: What % of denied claims are written off without appeal?
5. Cost-per-claim rework: What does it cost your team to work one denied claim? 
6. Average net revenue at risk: What’s the dollar value of claims that are currently unworked past 60 days? 

If you can’t pull these numbers internally, that’s its own signal. An RCM partner should be helping you build this visibility, not just promising to improve outcomes you can’t currently measure. 

Questions most RFPs never ask 

Standard RFPs ask about technology, references, and pricing. The questions below go further. They’re designed to separate organizations that can demonstrate outcomes from those that describe intentions. 

1. What’s your overturn rate by payer and denial type?

Aggregate overturn rates obscure performance. A vendor with a strong overturn rate on straightforward coding denials and a weak rate on medical necessity disputes is a different partner than one with consistent performance across denial categories. Ask for performance broken out by denial type and payer. 

2. What’s your minimum economically workable claim?

If a vendor’s platform requires human review for every appeal, their effective floor is typically $3,000-$5,000. Below that, the labor cost exceeds the recovery value. Ask where their floor actually is and how they handle claims below it. If the answer is ‘we write those off,’ you’re leaving a recoverable population on the table. 

3. What happens to your institutional knowledge when staffturn over?

This is the question that reveals whether a vendor has a technology differentiator or just a staffing model. If their performance depends on the same 10 specialists who’ve been doing this for 5 years, you have a retention risk, not a platform. Ask how payer-specific knowledge and appeal strategy is captured and retained independent of individual staff. 

4. How do you handletimelyfiling risk? 

Most payers require resubmission within 90-180 days. If a vendor has a backlog, claims can age past filing deadlines and become permanently uncollectable. Ask: what’s their average backlog length, how do they triage timely filing risk, and what’s their SLA for accounts approaching deadline? 

5. What’s your compliance infrastructure?

Healthcare RCM operates under HIPAA, HITECH, and a patchwork of state patient communication laws. Ask specifically: what certifications do they hold, how are patient communications reviewed for compliance, and what’s their incident history in the last 3 years? ‘We’re HIPAA compliant’ is a floor, not a differentiator. 

6. Can youoperateacross the full continuum? 

If you’re evaluating a denial management vendor who can’t handle EBO or bad debt, you’re adding a vendor rather than solving the integration problem. Ask: do they operate across denial management, early out billing, bad debt recovery, and legal recovery? If not, you’re adding coordination overhead to your revenue cycle, not removing it. 

The metrics that matter most 

In order of diagnostic value: 

 

Red flags in the evaluation process 

Watch for these in vendor responses: 

• Aggregate-only performance data. If a vendor can only show you blended numbers across all clients and all denial types, they can’t show you what your specific situation will look like. That’s a data infrastructure problem. 

• ‘We’re implementing AI.’ Present tense counts. If their AI implementation is 6-18 months away, you’re buying a roadmap, not a platform. 

• Reference checks with no quantified outcomes. ‘They’re great to work with’ is not a reference. Ask for specific overturn rate improvement, cost-per-claim comparison, and abandonment rate change over a defined period. 

• No answer on the compliance architecture question. If they deflect or cite HIPAA certification without being able to describe their compliance review workflow, that’s worth noting. 

• Single-segment operation. A denial management vendor who can’t describe EBO or bad debt recovery as part of their offering is telling you they operate in one lane. That’s fine if you want one lane. If you want the continuum, that’s a different conversation. 

Structuring the contract 

A few principles worth considering before signing: 

Agreed baselines in the contract. The best RCM contracts define current-state baselines and tie improvement milestones to them. If a vendor won’t agree to contractual performance milestones, that tells you something about their confidence in the numbers they pitched. 

Timely filing protection. Make sure the contract specifies what happens to accounts that age past timely filing deadlines. Who bears the risk? What’s the notification requirement? This is where ‘we had a backlog’ quietly becomes your problem. 

Data continuity on termination. Ensure you can extract your claims history, outcome data, and appeal records in a usable format if you end the relationship. Some vendors make this difficult by design. 

Compliance audit rights. You should retain the right to audit your vendor’s compliance practices. If they object to this, that’s a significant signal. 

A word on AI claims 

Every RCM vendor is now presenting as ‘AI-powered.’ Most of them mean it differently. When evaluating AI claims, ask for specifics: 

• What does the AI actually do in your workflow? Classification? Draft writing? Prioritization? Outcome prediction? 

• Is the AI operating on your data or a generic model? Payer-specific training data produces meaningfully better results than general models. 

• What’s the human review step? AI appeal drafting without human review is a compliance risk. Any responsible platform has a structured approval workflow. 

• What’s the AI’s impact on overturn rate? If they can’t quantify the delta between their AI-assisted results and manual baseline, the ‘AI’ claim is aspirational. 

TSI’s PULSE platform answers each of these questions with specific data: 86% overturn rate, 43% increase in payment per appeal, 50% reduction in time-to-appeal, and a minimum workable claim that drops from $5,000 to $500. Those numbers are the output of the AI workflow, not a vendor aspiration. 

Frequently asked questions

Implementation timelines vary by scope and EHR environment. Denial management integration typically runs 60-90 days; full EBO program setup usually adds 30 days. Transitions are more complex when multiple vendors are being consolidated into a single partner.

Price per claim matters, but it’s secondary to yield. A vendor charging $35 per claim with a 70% overturn rate generates more net revenue than a vendor charging $25 with a 45% rate. Focus on cost-per-recovered-dollar, not cost-per-claim-worked.

Most contracts run 2-3 years with renewal options. Shorter terms are increasingly available for denial management specifically. Be wary of extremely long contracts without defined performance milestones; they typically favor the vendor.

Pull your denial rate from your EHR billing module, your overturn rate from whatever claims tracking system you use, and your abandonment rate from the difference between total denials and submitted appeals. If your current systems can’t produce these numbers, that’s your first evaluation criterion: the new partner needs to build this visibility.

Implementation timelines vary by scope and EHR environment. Denial management integration typically runs 60-90 days; full EBO program setup usually adds 30 days. Transitions are more complex when multiple vendors are being consolidated into a single partner.

Price per claim matters, but it’s secondary to yield. A vendor charging $35 per claim with a 70% overturn rate generates more net revenue than a vendor charging $25 with a 45% rate. Focus on cost-per-recovered-dollar, not cost-per-claim-worked.

Most contracts run 2-3 years with renewal options. Shorter terms are increasingly available for denial management specifically. Be wary of extremely long contracts without defined performance milestones; they typically favor the vendor.

Pull your denial rate from your EHR billing module, your overturn rate from whatever claims tracking system you use, and your abandonment rate from the difference between total denials and submitted appeals. If your current systems can’t produce these numbers, that’s your first evaluation criterion: the new partner needs to build this visibility.

TSI Healthcare RCM operates across denial management, EBO, bad debt recovery, and legal recovery, with PULSE achieving an 86% overturn rate and a minimum workable claim of $500. If you want to see how that compares to your current program’s baselines, contact TSI for a complimentary revenue cycle assessment.

Frequently Asked Questions

How do I evaluate a healthcare RCM partner?

Start by pulling your current baseline metrics, including initial denial rate, overturn rate, time-to-appeal, claim abandonment rate, cost-per-claim rework, and average net revenue at risk. Then ask for performance broken out by payer and denial type, compliance details, timely filing handling, and whether the vendor can support the full revenue cycle continuum.

What metrics matter most when choosing a healthcare RCM partner?

The post highlights denial overturn rate, time-to-appeal, claim abandonment rate, cost per claim rework, minimum workable claim, and patient satisfaction impact as the most diagnostic metrics. It also recommends asking for fully loaded cost, breakdowns by denial type, and results that show how the vendor performs in your specific situation.

Why is baseline data important before hiring a healthcare RCM partner?

Without a baseline, you cannot measure whether the partner is improving anything. The guide says to know your current denial rate, overturn rate, time-to-appeal, claim abandonment rate, and cost-per-claim before signing. Otherwise, you are measuring effort rather than outcomes.

What should I ask a healthcare RCM partner about AI?

Ask what the AI actually does in the workflow, whether it uses your data or a generic model, what human review step exists, and what measurable impact it has on overturn rate. The post warns that AI appeal drafting without human review is a compliance risk and that vague AI claims are not enough.

What are the red flags when selecting a healthcare RCM partner?

Red flags include aggregate-only performance data, claims that AI is coming later instead of being operational now, reference checks without quantified outcomes, no clear compliance architecture, and single-segment offerings that cannot support the full continuum. The post also flags resistance to contractual baselines, audit rights, and data continuity on termination.